Literature DB >> 25028190

In vitro toxicity of grey MTA in comparison to white MTA on human periodontal ligament fibroblasts.

S N Al-Haj Ali1, S H Al-Jundi, D J Ditto.   

Abstract

AIM: This was to define and compare the in vitro toxicity of grey MTA with that of white MTA on cultured human periodontal ligament (PDL) fibroblasts.
METHODS: PDL cells were obtained from sound first permanent molars and cultured in Dulbecco's Modified Eagle's Medium. Cultures were subjected to different concentrations of grey and white MTA (0.5, 5, 50 and 500 µg/ml) for 24 h at 37 °C. Cells that were not exposed to grey or white MTA served as the negative control. In vitro toxicity was assessed using MTT assay. STATISTICS: The results were compared using ANOVA and Tukey statistical tests (p < 0.05).
RESULTS: White MTA presented higher in vitro toxicity than grey MTA. However, the differences were almost insignificant (p > 0.05).
CONCLUSION: Both colours of MTA are biocompatible since they were both able to preserve PDL fibroblasts for up to 24 h. MTA is as a promising alternative in pulpotomy of primary teeth.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25028190     DOI: 10.1007/s40368-014-0134-z

Source DB:  PubMed          Journal:  Eur Arch Paediatr Dent        ISSN: 1818-6300


  27 in total

1.  Cultured pulp fibroblasts: are they suitable for in vitro cytotoxicity testing?

Authors:  C W van Wyk; A Olivier; J S Maritz
Journal:  J Oral Pathol Med       Date:  2001-03       Impact factor: 4.253

2.  Cytotoxicity of dental alloys, metals, and ceramics assessed by millipore filter, agar overlay, and MTT tests.

Authors:  G Sjögren; G Sletten; J E Dahl
Journal:  J Prosthet Dent       Date:  2000-08       Impact factor: 3.426

3.  Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth.

Authors:  R Caicedo; P V Abbott; D J Alongi; M Y Alarcon
Journal:  Aust Dent J       Date:  2006-12       Impact factor: 2.291

4.  In vitro toxicity of MTA compared with other primary teeth pulpotomy agents.

Authors:  José Vitor Nogara Borges de Menezes; Esther Rieko Takamori; Maria Francisca Thereza Borro Bijella; José Mauro Granjeiro
Journal:  J Clin Pediatr Dent       Date:  2009       Impact factor: 1.065

Review 5.  In vitro models of biocompatibility: a review.

Authors:  C T Hanks; J C Wataha; Z Sun
Journal:  Dent Mater       Date:  1996-05       Impact factor: 5.304

6.  Mineral trioxide aggregate pulpotomies: a case series outcomes assessment.

Authors:  David E Witherspoon; Joel C Small; Gary Z Harris
Journal:  J Am Dent Assoc       Date:  2006-05       Impact factor: 3.634

7.  Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.

Authors:  H Noorollahian
Journal:  Br Dent J       Date:  2008-04-18       Impact factor: 1.626

Review 8.  Pulpotomy therapy in primary teeth: new modalities for old rationales.

Authors:  D M Ranly
Journal:  Pediatr Dent       Date:  1994 Nov-Dec       Impact factor: 1.874

Review 9.  Mineral trioxide aggregate material use in endodontic treatment: a review of the literature.

Authors:  Howard W Roberts; Jeffrey M Toth; David W Berzins; David G Charlton
Journal:  Dent Mater       Date:  2007-06-21       Impact factor: 5.304

10.  Comparison of mineral trioxide aggregate's composition with Portland cements and a new endodontic cement.

Authors:  Saeed Asgary; Mohammad Jafar Eghbal; Masoud Parirokh; Jamileh Ghoddusi; Sanam Kheirieh; Frank Brink
Journal:  J Endod       Date:  2008-12-13       Impact factor: 4.171

View more
  2 in total

1.  In vitro toxicity of formocresol, ferric sulphate, and grey MTA on human periodontal ligament fibroblasts.

Authors:  S N Al-Haj Ali; S H Al-Jundi; D J Ditto
Journal:  Eur Arch Paediatr Dent       Date:  2014-10-29

2.  Cytotoxicity of Various Endodontic Materials on Stem Cells of Human Apical Papilla.

Authors:  Eshagh Ali Saberi; Hamed Karkehabadi; Narges Farhad Mollashahi
Journal:  Iran Endod J       Date:  2015-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.